Specialized Biomarker Focus Oxford Biomedical Research specializes in developing assay kits and recombinant proteins targeting oxidative stress and chronic inflammation biomarkers, which are increasingly relevant in personalized medicine. Physicians and pharmaceutical companies exploring diagnostics and targeted therapies in these areas could be prime customers for their innovative solutions.

Unique Assay Technologies The company’s proprietary CypExpress™ system, offering high-yield, stable human P450 enzyme preparations, provides a unique product for drug metabolism and metabolite profiling. This positions OBR as a critical partner for drug discovery and development teams needing reliable, scalable enzyme-based assays.

Growth and Market Potential With revenue ranging from one to ten million dollars and a focus on niche biomedical research products, Oxford Biomedical Research is poised for growth as demand for biomarker and metabolism research accelerates, especially among biotech and pharmaceutical firms expanding their R&D pipelines.

Target Customer Segments OBR’s customer base likely includes research institutions, biotech firms, and pharmaceutical companies seeking specialized assay kits and enzyme products. Tailoring outreach to these sectors can generate increased sales opportunities, particularly in early-stage R&D projects.

Digital Presence & Engagement With a website built on robust platforms like Drupal and integrated analytics tools, OBR can leverage data-driven marketing strategies to increase visibility among target buyers. Engaging content and digital campaigns can enhance lead generation and foster long-term customer relationships.